Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, Adamchuk H, Salgado M, Yardley DA, Berzoy O, Zamora-Aunon P, Chan D, Spera G, Xue C, Ferreira E, Badovinac Crnjevic T, Perez-Moreno PD, Lopez-Valverde V, Steinseifer J, Fernando TM, Moore HM, Fasching PA; coopERA Breast Cancer study group. Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study. Lancet Oncol. 2023 Sep;24(9):1029-1041. doi: 10.1016/S1470-2045(23)00268-1. PubMed PMID: 37657462.
AÑO: 2023; IF: 51.1
37657462
Rosado-Jimenez L, Mestre-Terkemani Y, Garcia-Aliaga A, Marin-Vera M, Macias-Cerrolaza JA, Sarabia-Meseguer MD, Garcia-Hernandez MR, Zafra-Poves M, Sanchez-Henarejos P, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia. Adv Lab Med. 2023 Sep 22;4(3):279-287. doi: 10.1515/almed-2023-0103. eCollection 2023 Sep. PubMed PMID: 38075165; PubMed Central PMCID: PMC10701504.
AÑO: 2023
38075165
Royo-Villanova M, Minambres E, Sanchez JM, Torres E, Manso C, Ballesteros MA, Parrilla G, de Paco Tudela G, Coll E, Perez-Blanco A, Dominguez-Gil B. Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study. Am J Transplant. 2023 Sep 20:S1600-6135(23)00696-2. doi: 10.1016/j.ajt.2023.09.008. Online ahead of print. PubMed PMID: 37739346.
AÑO: 2023; IF: 8.8
37739346
Sanchez Martinez DA, Carrasco Picazo JP, Estrella Porter PD, Ruiz-Montero R, Aginagalde Llorente AH, Garcia-Camacho E, Navarro J, Cerame Del Campo A. Resident physician duty hours, resting times and European Working Time Directive compliance in Spain: a cross-sectional study. Hum Resour Health. 2023 Aug 24;21(1):70. doi: 10.1186/s12960-023-00857-x. PubMed PMID: 37620869; PubMed Central PMCID: PMC10463816.
AÑO: 2023
37620869
Martin-Broto J, Martinez-Garcia J, Moura DS, Redondo A, Gutierrez A, Lopez-Pousa A, Martinez-Trufero J, Sevilla I, Diaz-Beveridge R, Solis-Hernandez MP, Carnero A, Perez M, Marcilla D, Garcia-Foncillas J, Romero P, Fernandez-Jara J, Lopez-Lopez D, Arribas I, Hindi N. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A. Signal Transduct Target Ther. 2023 Oct 25;8(1):405. doi: 10.1038/s41392-023-01661-8. PubMed PMID: 37875500; PubMed Central PMCID: PMC10598203.
AÑO: 2023; IF: 39.3
37875500
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL